Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SRPT

Recent news which mentions SRPT

< Previous 1 2 3 Next >
3 Gene Editing Stocks With the Best Long-Term Potential
Tickers CRSP GNOM MYGN NTLA
Tags SRPT Stocks to Buy GNOM
From InvestorPlace
9 Analysts Have This to Say About Sarepta Therapeutics
Tickers SRPT
Tags Market News SRPT Benzinga
From Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
Tickers ABBV CRSP CVAC DIS
Tags PFE Market News INCY
From InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
Tickers CRSP SRPT VRTX
Tags Recent Press Releases VRTX SRPT
From Motley Fool
BTIG Maintains Buy Rating for Sarepta Therapeutics: Here's What You Need To Know
Tickers SRPT
Tags Market News SRPT BZI/AAR/UPDATE
From Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
Tickers AZN GH SRPT
Tags GH AZN Recent Press Releases
From Motley Fool
Analyst Ratings for Sarepta Therapeutics
Tickers SRPT
Tags Benzinga BZI/AAR SRPT
From Benzinga
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
Tickers SRPT
Tags Market News SRPT Recent Press Releases
From Motley Fool
Earnings Scheduled For November 2, 2022
Tickers QMCO QRVO RACE RARE
Tags XHR SKT WTS
From Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
Tickers DNA NVCR SRPT
Tags SRPT Market News DNA
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
Tickers CRSP SRPT
Tags Market News SRPT CRSP
From Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
Tickers AAPL BILL LIN OPEN
Tags Price Target PT Changes News
From Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
Tickers SRPT
Tags BZI/AAR Benzinga Market News
From Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
Tickers PEPG SRPT
Tags Benzinga SRPT Trading Ideas
From Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
Tickers CNA COIN SRPT
Tags Benzinga Insider Trades SRPT
From Benzinga
Analyst Ratings for Sarepta Therapeutics
Tickers SRPT
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
Tickers SRPT
Tags Market News Movers Trading Ideas
From Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
Tickers SRPT
Tags Biotech News Health Care
From Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
Tickers CRSP MYGN SRPT
Tags SRPT Market News MYGN
From Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
Tickers SRPT
Tags Contracts SRPT Benzinga
From Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
Tickers SRPT
Tags Benzinga Guidance SRPT
From Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
Tickers SRPT
Tags Market News Health Care Biotech
From Benzinga
Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
Tickers SRPT
Tags SRPT Market News Recent Press Releases
From Motley Fool
Sarepta Therapeutics: Q2 Earnings Insights
Tickers SRPT
Tags Benzinga Market News Earnings
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Tickers ABBV ACIU ALLR AXLA
Tags VALN ALLR AXLA
From Benzinga
Earnings Scheduled For August 2, 2022
Tickers LUNG LXRX MAR MCHP
Tags News TRTX USAC
From Benzinga
Sarepta Therapeutics Earnings Preview
Tickers SRPT
Tags Benzinga BZI/EP SRPT
From Benzinga
Chevron, Amazon And Some Other Big Gainers From Friday
Tickers AMTD AMZN AXTI CROX
Tags CROX FIVN MITK
From Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
Tickers ABBV ADMP ARQT BMY
Tags ADMP Biotech Health Care
From Benzinga
Duchenne Gene Therapy Firm Sarepta Therapeutics' Earns 8% Price Target Hike From This Analyst
Tickers SRPT
Tags FDA General Price Target
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.